KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Net Margin (2016 - 2026)

AbbVie has reported Net Margin over the past 14 years, most recently at 10.92% for Q4 2025.

  • Quarterly Net Margin rose 1107.0% to 10.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.92% through Dec 2025, down 69.0% year-over-year, with the annual reading at 6.92% for FY2025, 69.0% down from the prior year.
  • Net Margin was 10.92% for Q4 2025 at AbbVie, up from 1.19% in the prior quarter.
  • Over five years, Net Margin peaked at 33.19% in Q1 2022 and troughed at 0.79% in Q1 2023.
  • The 5-year median for Net Margin is 10.87% (2024), against an average of 12.8%.
  • Year-over-year, Net Margin soared 2705bps in 2021 and then plummeted -3398bps in 2023.
  • A 5-year view of Net Margin shows it stood at 27.17% in 2021, then crashed by -40bps to 16.35% in 2022, then crashed by -65bps to 5.76% in 2023, then plummeted by -103bps to 0.15% in 2024, then skyrocketed by 7271bps to 10.92% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Net Margin are 10.92% (Q4 2025), 1.19% (Q3 2025), and 6.1% (Q2 2025).